• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Healthcare Blockchain Startup BurstIQ Nabs $5.5M For HIPAA-Compliant Blockchain Platform

Share:

October 7, 2019

BurstIQ, an Denver, CO-based provider of HIPAA-compliant blockchain solutions for the healthcare industry has raised $5.5M in Series A funding led by Elsewhere Partners. Elsewhere, a growth-stage venture capital firm which invests in capital-efficient B2B software companies outside of traditional venture capital hubs was drawn to BurstIQ due to its best-in-class blockchain product, strong traction with marquee enterprise customers and significant market opportunity.

Health Data Lives on Islands

Data is becoming increasingly critical to clinical, operational, and individual decision-making, and interest in products and partnerships that leverage data is exploding. However, health data is largely siloed, inaccessible, non-standardized across systems, and difficult to understand, use and share.

Combining The Power of Blockchain, Big Data, And Intelligence

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

Founded in 2015 to address these challenges, BurstIQ is the first and only blockchain company to provide secure, HIPAA-compliant blockchain platform services for on-chain data management, complex data ownership, and granular consent. BurstIQ’s proprietary platform is used by large enterprises, startups and government agencies to power identity services, interoperability, care coordination and consumer engagement programs, consumer IoT solutions, secure data access management, data marketplaces and more.

Health data from disparate sources are combined to create individual LifeGraphs within the platform. LifeGraphs then form the basis for the HealthWallet, that enables patients, businesses, and researchers to securely share, sell, license, loan, or donate their data. The company believes that within the next five years, data will become the currency that drives the healthcare industry, and BurstIQ will drive the marketplace.

Recent Traction/Partnerships

The Series A funding marks the first major institutional funding round for BurstIQ and has been financially sustainable since 2016, generating millions in annual revenue through commercial partnerships with marquee customers such as Empiric Health, Medical Group Management Association (MGMA) and Colorado Regional Health Information Organization (CORHIO). The company plans to use the funding to expand sales, marketing, and network growth.

Partnering with Elsewhere Partners will allow BurstIQ to accelerate market penetration, product innovation and organizational growth. Sloane Child, Vice President at Elsewhere Partners, comments, “We are excited about the future of BurstIQ and confident that their state-of-the-art blockchain platform and seasoned management team, in conjunction with the growing demand for secure and compliant healthcare data, will enable BurstIQ to continue to grow and capitalize on the opportunities ahead.”

Date: October 07, 2019

Source: HedgeMaven

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Tetraphase Announces Amendment to Merger Agreement with AcelRx Pharmaceuticals for Increased ConsiderationTetraphase Announces Amendment to Merger Agreement with AcelRx Pharmaceuticals for Increased Consideration
  • Amazon Introduces Software to Mine Patient Health Records to Find EfficienciesAmazon Introduces Software to Mine Patient Health Records to Find Efficiencies
  • GeneCentric Therapeutics Licenses Pancreatic Cancer Subtyping Technology from University of North CarolinaGeneCentric Therapeutics Licenses Pancreatic Cancer Subtyping Technology from University of North Carolina
  • Ruth Health Scores $2.4M for Pregnancy, Postpartum SupportRuth Health Scores $2.4M for Pregnancy, Postpartum Support
  • UPMC Spinout Astrata Launches NLP Platform to Improve Value-Based CareUPMC Spinout Astrata Launches NLP Platform to Improve Value-Based Care
  • Alight to acquire Hodges-Mace to enhance its health and voluntary benefit capabilities and expand suite of solutions for employers of all sizesAlight to acquire Hodges-Mace to enhance its health and voluntary benefit capabilities and expand suite of solutions for employers of all sizes
  • ALSA Ventures Closes US$59 Million European Biotech Venture Capital FundALSA Ventures Closes US$59 Million European Biotech Venture Capital Fund
  • Global Pulmonary Sarcoidosis Pipeline Insight Market Report 2021 Featuring Novartis, ATyr Pharma, Relief Therapeutics, AI Therapeutics, & Sarcomed USAGlobal Pulmonary Sarcoidosis Pipeline Insight Market Report 2021 Featuring Novartis, ATyr Pharma, Relief Therapeutics, AI Therapeutics, & Sarcomed USA

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications